About 100 reports

Most common type of mental health disorders are: attention deficit hyperactivity disorder, anxiety, mood disorders, schizophrenia, dementia, bipolar disorder etc.

  • Neurological Disorder
  • World
  • AstraZeneca PLC
  • Biogen Idec Inc.
  • Eli Lilly & Co.
  • Bipolar disorder
  • Bipolar disorder

Diagnostic and Statistical Manual of Mental Disorders (DSM) have outlined four types of bipolar including, bipolar I disorder is diagnosed when a person displays manic or mixed ##. ##. ## BIPOLAR DISORDERS episodes that last at least seven da

  • Neurological Disorder
  • World
  • Market Size
  • Compumedics Limited
  • Medtronic, Inc.
  • Central Nervous System Drugs Market Characteristics

bipolar disorders and anxiety.

  • Neurological Disorder
  • World
  • Biogen Idec Inc.
  • Novartis AG
  • Pfizer Inc.
  • Global Medical Cannabis Market Overview - Mental Disorders

Patients use cannabis for symptoms of PTSD, anxiety, depression, ADHD, bipolar disorder, opiate million in 2018, growing at a CAGR of ##. ##% during the historical period of 2014-2018.

  • Marijuana
  • Neurological Disorder
  • World
  • Market Size
  • Canopy Growth Corporation
  • MARKET DEFINITION
  • SEGMENTATION BY END-USER

Some of the disorders are anxiety and panic disorders, bipolar disorder, depression, and substance abuse disorder.

  • Neurological Disorder
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Anti-chorea effect
  • Market scenario by drug-class

Antipsychotics Antipsychotics are the therapeutic agents used to manage psychotic symptoms such as delusions, hallucinations, or mania in bipolar disorder and schizophrenia.

  • Neurological Disorder
  • World
  • Lundbeck Inc.
  • Prana Biotechnology Limited
  • Teva Pharmaceutical Industries Ltd.

WHILE AT NIMH, HIS AREA OF RESEARCH WAS FOCUSING ON THE NEUROBIOLOGY OF DEPRESSION AND BIPOLAR DISORDER.

  • Neurological Disorder
  • Australasia
  • Australia
  • Oceania
  • Medtronic, Inc.
  • Bipolar Disorder Patients in the US; 2017-2025 ('000)
  • US Tardive Dyskinesia Market Number of Patients by Segments; 2017

It is divided into bipolar I disorder if there is at least one manic episode and bipolar II disorder if there are at least one hypomanic episode and one major depressive episode.

  • Neurological Disorder
  • United States
  • Market Size
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • ULTRASONIC ASPIRATOR MARKET IN EMEA

Source: Technavio MARKET OVERVIEW ULTRASONIC ASPIRATOR MARKET IN EMEA The incidence rate of neurological disorders, such as dementia, bipolar disorder, and cerebral palsy, is high in the region.

  • Neurological Disorder
  • World
  • Demand
  • Forecast
  • Olympus Corporation

LAMICTAL HAS ALSO BEEN APPROVED FOR THE MAINTENANCE TREATMENT OF BIPOLAR I DISORDER IN THE US, AND THE PREVENTION OF DEPRESSIVE EPISODES IN PATIENTS WITH BIPOLAR I DISORDER IN THE EU AND JAPAN (GSK, 2003).

  • Neurological Disorder
  • United States
  • Forecast
  • Eisai Co., Ltd.
  • GW Pharmaceuticals plc
  • 3.2 Information sources

The central nervous system (CNS) disorders include several disorders and conditions such as epilepsy, Parkinson' s disease, bipolar disorder, and depression.

  • Neurological Disorder
  • Daiichi Sankyo Company
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.

IT IS USED FOR THE MANAGEMENT OF ANXIETY DISORDERS AND SHORT-TERM RELIEF OF THE SYMPTOMS OF ANXIETY, EXCLUDING MILD AND MODERATE DEGREES OF ANXIETY AND ANXIETY-RELATED DISORDERS.

  • Neurological Disorder
  • World
  • Forecast
  • Antares Pharma, Inc.
  • Sanofi S.A.

People with family members suffering from schizophrenia and bipolar disorder have a greater disposition to these conditions, and as a result, hereditary mental health problems support sustained demand.

  • Mental Health
  • Neurological Disorder
  • United Kingdom
  • Demand
  • Forecast
  • SPN-810 SWOT ANALYSIS, 2015
  • RISK FACTORS AND COMORBIDITIES FOR ADHD

DAYTRANA MAY ALSO EXACERBATE THE SYMPTOMS OF PSYCHIATRIC DISORDERS, SUCH AS BIPOLAR DISORDER, OR AGGRESSION.

  • Neurological Disorder
  • Demand
  • Market Size
  • Novartis AG
  • Supernus Pharmaceuticals, Inc.

For instance, in December 2015, researchers at Mayo Clinic identified a protein biomarker panel for bipolar disorder using Myriad' s DiscoveryMAP.

  • Neurological Disorder
  • World
  • Market Size
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.
  • 7MM, Diagnosed Prevalent Cases of ADHD, Ages ≥3 Years, Both Sexes, N, 2014 and 2024
  • Risk Factors and Comorbidities for ADHD

Common comorbidities include learning disabilities, oppositional defiant disorder, conduct disorder, obsessive-compulsive disorder, tic disorders, substance use disorders (SUD), anxiety disorders, bipolar disorder, and depressio

  • Neurological Disorder
  • Germany
  • Japan
  • United States
  • Forecast

(Australia) ##.

  • Neurological Disorder
  • Specialty Hospital
  • United States
  • Market Competition
  • Market Shares
  • PIPELINE BY JOHNSON & JOHNSON, H2 2019
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2019 (CONTD..1), H2 2019

disorder, bipolar disorder and inflammatory bowel disease.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • Biosceptre International Limited
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H1 2019
  • PIPELINE BY JOHNSON & JOHNSON, H1 2019

disorder, bipolar disorder and inflammatory bowel disease.

  • Neurological Disorder
  • Therapy
  • World
  • Product Initiative
  • Biosceptre International Limited
  • SMALL MOLECULES TO ACTIVATE SMN2 FOR SPINAL MUSCULAR ATROPHY - DRUG PROFILE
  • SMALL MOLECULES TO ACTIVATE SMN2 FOR SPINAL MUSCULAR ATROPHY - DRUG PROFILE

Burghes on SMA and other genetic neuromuscular disorders.

  • Neurological Disorder
  • United States
  • World
  • Product Initiative
  • AveXis, Inc.
  • May 01, 2017: Genomind Reaches Milestone, Expands Headquarters to Meet Demand
  • Jan 09, 2017: Genomind Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments

Perlis, MD, MSc, whose research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder.

  • Neurological Disorder
  • United States
  • Company
  • Deals & Alliance
  • Genomind, Inc.

Patients were required to have at least a one-year history of migraine (with or without aura), consistent with a diagnosis according to the International Classification of Headache Disorders.

  • Mental Health
  • Neurological Disorder
  • United States
  • Product Initiative
  • Allergan plc

This agreement enables Mapi Pharma to develop and commercialize Risperidone LAI for the treatment of schizophrenia and bipolar disorder.

  • Neurological Disorder
  • Pharmaceutical
  • China
  • Israel
  • Mapi - Pharma Ltd.
  • POPULATION BIO INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • INBORN GENE OR CHROMOSOME ALTERATIONS DIAGNOSTIC TESTS - PIPELINE PRODUCTS BY STAGE OF DEVELOPMENT

SMA AFFECTS APPROXIMATELY ONE IN EVERY ##, ## INFANTS, WHILE ONE IN ## PEOPLE IS A CARRIER FOR THE DISORDER.

  • Clinical Trial
  • Hospital
  • Mental Health
  • Neurological Disorder
  • AutoGenomics, Inc.

In June 2003, the US Food and Drug Administration approved Lamictal for the long-term maintenance treatment of adults with bipolar I disorder.

  • Bipolar Disorder
  • Mental Health
  • Neurological Disorder
  • Pathology
  • United States

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review.

  • Neurological Disorder
  • United States
  • Huntington Study Group
  • Ionis Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Deal Rationale

In addition, we intend to initiate a Phase ## clinical trial for ZX## in Lennox Gastaut Syndrome (LGS), another rare and severe childhood-onset epilepsy disorder, in the second half of 2017.

  • Neurological Disorder
  • Therapy
  • United States
  • Company
  • Zogenix, Inc.

THESE STRONG AND VERY IMPORTANT RESULTS TAKES US ONE STEP CLOSER IN REACHING OUR VISION: " IMPROVING THE LIVES OF PEOPLE WITH MENTAL DISORDERS" .

  • Drug Development
  • Healthcare
  • Neurological Disorder
  • United States
  • Company

It also offers treatments for acid reflux disease, infectious diseases, bipolar I disorder, schizophrenia, alzheimer' s disease, epilepsy, migraine prevention and treatment.

  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Janssen Biotech, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Reddy' s Under Fed Conditions GDCT## NCT##, P-##/ ##-## Central Nervous System Absence Seizure, Bipolar Disorder (Manic Depression), Complex Partial Seizure, Epilepsy, Mania, Migraine Completed Phase I Interventional divalproex sodium DR Dr.

  • Drug Development
  • Neurological Disorder
  • World
  • Product Initiative
  • Pfizer Inc.